Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1903 (LINC01903) is a human long non-coding RNA (lncRNA), specifically belonging to the subclass of long intergenic non-coding RNAs (lincRNAs), which are non-protein coding transcripts longer than 200 nucleotides and do not overlap with protein-coding genes[3][5][7]. LincRNAs such as LINC01903 have diverse molecular functions, most notably in modulating gene expression through chromatin remodeling, regulating transcription, and influencing genome architecture—often in a tissue-specific manner[5][7]. While thousands of lincRNAs are annotated and some play important roles in gene regulation and disease, the biological role and disease relevance of LINC01903 itself is not currently defined nor associated with drug interactions or validated as a therapeutic target[1][3][5]. There is no evidence to support its classification as a receptor, enzyme, transporter, transcription factor, or any conventional therapeutic target. Its clinical utility, if any, has not been established, and there are no known biomarkers, drug interactions, or specific safety concerns associated with LINC01903 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1903 (LINC01903).